CTLA4 and breast cancer: In pathological conditions such as BC, they include programmed cell death 1 (PD-1), cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and its ligands (PD-L1/2) and T-cell immunoglobulin and mucin domain containing protein-3 (TIM-3) (24).